GlassScriptPhysician profile
Tamara Kate Mccullars
NPI 1023609138
$616.53
in general payments reported to CMS, 2019-2025
13 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $53.95 · 2023: $173 · 2024: $150 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.57 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $125.67 | 2024-2025 | Ozempic, Wegovy |
| Abbvie INC. | $103.78 | 2021-2023 | |
| Astellas Pharma US INC | $99.95 | 2023 | |
| Myovant Sciences INC. | $52.19 | 2021-2022 | |
| Daiichi Sankyo INC. | $46.67 | 2021-2023 | Injectafer |
| Hologic Sales and Service, LLC | $39.60 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Noven Therapeutics, LLC | $35.88 | 2024 | Xelstrym |
| Sumitomo Pharma America, INC. | $27.95 | 2023-2024 | Myfembree |
| Phathom Pharmaceuticals, INC. | $20.79 | 2024 | Voquezna |
| Pfizer INC. | $20.29 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.83 | 2025 | Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $14.60 | 2024 | |
| Agile Therapeutics, INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Mccullars listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.